Skip to content

News

October 20, 2016

Young Victim of Stroke

Oct 20, 2016: Dr. Achal Singh Achrol, Director of Neurovascular Surgery and Neurocritical Care is among the experts to speak with SELF about the model Katie May’s death from stroke.
September 26, 2016

Live Stream of Supraorbital Surgery at CNS

Monday September 25th 2016, 9:15-9:45am: Dr. Daniel F. Kelly performs a live Endoscopic Supraorbital Surgery at the Congress of Neurological Surgeons (CNS) annual meeting in San Diego. Sponsored by Karl Storz Endoscopy, KLS Martin Group & Stryker Corporation. Check it out at the conference.
August 29, 2016

Next Generation Radiation Treatment Comes To PNI

  • News
  • 3 min
Some brain and pituitary tumors may require radiation therapy. The Varian Edge system at our center delivers radiation treatment quickly and more precisely.
August 14, 2016

Deep Brain Stimulation of the Basolateral Amygdala

Aug 10, 2016: Jean-Philippe Langevin, MD, director of restorative neurosurgery at Pacific Movement Disorders Center has published a paper in Brain Sciences. This method paper describes the technique used to perform DBS of the amygdala.
July 13, 2016

Introducing the Pacific Adult Hydrocephalus Center

  • News
  • 2 min
Pacific Neuroscience Institute announces Pacific Adult Hydrocephalus Center led by neurosurgeon, Dr. Garni Barkhoudarian and neurologist, Dr. Daniel Franc.
June 26, 2016

Voyager headband device fights spread of brain tumors

June 23, 2016: Dr. Garni Barkhoudarian talks to abc7.com about the clinical trial at the Saint John’s Cancer Institute studying the innovative approach to battling cancer. A new headband device called Voyager uses electromagnetic energy to stop aggressive brain tumor cancer cells from dividing and spreading.
June 23, 2016

Mifepristone Accelerates Recovery in Cushing’s Patient

June 26, 2016: Endocrinologist Dr. Pejman Cohen has published a Cushing’s disease case study in Hindawi. The use of mifepristone enabled a patient who had struggled with low cortisol causing fatigue, body aches, nausea, and poor overall quality of life for over 6 years to rapidly recover.
June 2, 2016

Tumor-killing virus nearly doubles survival time of brain cancer patients in a small trial

June 1, 2016: A virus-drug combo has shown to almost double the life expectancy of brain cancer patients in a small clinical trial. The virus, Toca 511, infiltrates cancer cells with broken defense systems. Inside the cells, Toca 511 inserts the genetic code for a foreign protein—the yeast enzyme cytosine deaminase (CD)— into the DNA. The cancer cell unwittingly produces the enzyme which acts as a drug detonator. In the second phase of treatment, an inactive form of a cancer drug called 5-FU, or 5-fluorouracil is administered. It can move through the brain safely in its inactive state. When it reaches the tumor cells it is activated by the CD enzyme and destroys the cancer cells. PNI’s Dr. Santosh Kesari is one of the investigators on this study which has been published in Science Translational Medicine.
June 2, 2016

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma

Tag-team attack on glioma Toca FC (extended-release 5-fluorocytosine) and Toca 511 (vocimagene amiretrorepvec) are an investigational therapeutic combination for glioma, consisting of two parts: a prodrug that is inactive on its own and a modified virus that infects the tumor and delivers an enzyme, which then activates the drug and allows it to kill the glioma cells. Cloughesy et al. tested this therapy in 45 human patients with recurrent or progressive high-grade glioma and discovered that the treatment was well tolerated and improved survival compared to an external control group. In addition, the authors identified a gene signature that correlated with response to the treatment, which may help identify the patients most likely to benefit from this approach.
June 2, 2016

Precision Cancer Care in 2016

May 27, 2016: Thomson Reuters publication ‘Medical Device Daily’ article about the Saint John’s Cancer Institute hosted Precision Medicine 2016 Conference. Pacific Neuroscience Institute’s Dr. Daniel Kelly and Dr. Santosh Kesari were among those mentioned and quoted.